Erythropoietin and the hypoxic brain

Journal of Experimental Biology

Volumn 207, Issue 18, 2004, Pages 3233-3242

  Marti, Hugo H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiogenesis; Hypoxia; Ischaemia; Neuroprotection; Preconditioning; Tolerance; VEGF

Indexed keywords

MAMMALIA;

EID: 4644318784     PISSN: 00220949     EISSN: None     Source Type: Journal    
DOI: 10.1242/jeb.01049     Document Type: Review

References (101)

1. Agnello, D., Bigini, P., Villa, P., Mennini, T., Cerami, A., Brines, M. and Ghezzi, P. (2002). Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res. 952, 128-134.
2. Anagnostou, A., Lee, E. S., Kessimian, N., Levinson, R. and Steiner, M. (1990). Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc. Natl. Acad. Sci. USA 87, 5978-5982.
3. Anagnostou, A., Liu, Z.-Y., Steiner, M., Chin, K., Lee, E. S., Kessimian, N. and Noguchi, C. T. (1994). Erythropoietin-receptor mRNA expression in human endothelial cells. Proc. Natl. Acad. Sci. USA 91, 3974-3978.
4. Assandri, R., Egger, M., Gassmann, M., Niggli, E., Bauer, C., Forster, I. and Görlach, A. (1999). Erythropoietin modulates intracellular calcium in a human neuroblastoma cell line. J. Physiol. Lond. 516, 343-352.
5. Baciu, I., Oprisiu, C., Derevenco, P., Vasile, V., Muresan, A., Hriscu, M. and Chis, I. (2000). The brain and other sites of erythropoietin production. Rom. J. Physiol. 37, 3-14.
6. Bernaudin, M., Marti, H. H., Roussel, S., Divoux, D., Nouvelot, A., MacKenzie, E. T. and Petit, E. (1999). A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19, 643-651.
7. Bernaudin, M., Bellail, A., Marti, H. H., Yvon, A., Vivien, D., Duchatelle, I., MacKenzie, E. T. and Petit, E. (2000). Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia 30, 271-278.
8. Bittorf, T., Büchse, T., Sasse, T., Jaster, R. and Brock, J. (2001). Activation of the transcription factor NF-κB by the erythropoietin receptor: structural requirements and biological significance. Cell. Signalling 13, 673-681.
9. Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M. and Cerami, A. (2000). Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA 97, 10526-10531.
10. Bruick, R. K. and McKnight, S. L. (2001). A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340.
11. Buemi, M., Allegra, A., Corica, F., Floccari, F., D'Avella, D., Aloisi, C., Calapai, G., Iacopino, G. and Frisina, N. (2000). Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration. Nephrol. Dial. Transplant. 15, 422-423.
12. Buemi, M., Cavallaro, E., Floccari, F., Sturiale, A., Aloisi, C., Trimarchi, M., Corica, F. and Frisina, N. (2003). The pleiotropic effects of erythropoietin in the central nervous system. J. Neuropathol. Exp. Neurol. 62, 228-236.
13. Cai, Z., Manalo, D. J., Wei, G., Rodriguez, E. R., Fox-Talbot, K., Lu, H., Zweier, J. L. and Semenza, G. L. (2003). Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108, 79-85.
14. Calapai, G., Marciano, M. C., Corica, F., Allegra, A., Parisi, A., Frisina, N., Caputi, A. P. and Buemi, M. (2000). Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur. J. Pharmacol. 401, 349-356.
15. Calvillo, L., Latini, R., Kajstura, J., Leri, A., Anversa, P., Ghezzi, P., Salio, M., Cerami, A. and Brines, M. (2003). Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc. Natl. Acad. Sci. USA 100, 4802-4806.
16. Carlini, R. G., Reyes, A. A. and Rothstein, M. (1995). Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int. 47, 740-745.
17. Carnot, P. and Deflandre, C. (1906a). Sur l'activité hémopoiétique des différents organes au cours de la régénération du sang. C. R. Acad. Sci. Paris 143, 432-435.
18. Carnot, P. and Deflandre, C. (1906b). Sur l'activité hémopoiétique du sérum au cours de la régé nération du sang. C. R. Acad. Sci. Paris 143, 384-386.
19. Chavez, J. C., Agani, F., Pichiule, P. and LaManna, J. C. (2000). Expression of hypoxia-inducible factor-1α in the brain of rats during chronic hypoxia. J. Appl. Physiol. 89, 1937-1942.
20. Chikuma, M., Masuda, S., Kobayashi, T., Nagao, M. and Sasaki, R. (2000). Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus. Am. J. Physiol. 279, E1242-E1248.
21. Chin, K., Yu, X., Beleslin-Cokic, B., Liu, C., Shen, K., Mohrenweiser, H. W. and Noguchi, C. T. (2000). Production and processing of erythropoietin receptor transcripts in brain. Brain Res. Mol. Brain Res. 81, 29-42.
22. Chong, Z. Z., Kang, J. Q. and Maiese, K. (2002). Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106, 2973-2979.
23. Chong, Z. Z., Kang, J. Q. and Maiese, K. (2003). Erythropoietin: cytoprotection in vascular and neuronal cells. Curr. Drug Targets Cardiovasc. Haematol. Disord. 3, 141-154.
24. Dame, C., Juul, S. E. and Christensen, R. D. (2001). The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol. Neonate 79, 228-235.
25. Digicaylioglu, M. and Lipton, S. A. (2001). Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades. Nature 412, 641-647.
26. Digicaylioglu, M., Bichet, S., Marti, H. H., Wenger, R. H., Rivas, L. A., Bauer, C. and Gassmann, M. (1995). Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. Natl. Acad. Sci. USA 92, 3717-3720.
27. Dirnagl, U., Simon, R. P. and Hallenbeck, J. M. (2003). Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 26, 248-254.
28. Ehrenreich, H. and Siren, A. L. (2001). Neuroprotection - what does it mean? - what means do we have? Eur. Arch. Psyc. Clin. Neurosci. 251, 149-151.
29. Ehrenreich, H., Hasselblatt, M., Dembowski, C., Cepek, L., Lewczuk, P., Stiefel, M., Rustenbeck, H. H., Breiter, N., Jacob, S., Knerlich, F. et al. (2002). Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 8, 495-505.
30. Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A. et al. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
31. Erbayraktar, S., Grasso, G., Sfacteria, A., Xie, Q. W., Coleman, T., Kreilgaard, M., Torup, L., Sager, T., Erbayraktar, Z., Gokmen, N. et al. (2003). Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc. Natl. Acad. Sci. USA 100, 6741-6746.
32. Fisher, J. W. (2003). Erythropoietin: physiology and pharmacology update. Exp. Biol. Med. 228, 1-14.
33. Genc, S., Kuralay, F., Genc, K., Akhisaroglu, M., Fadiloglu, S., Yorukoglu, K., Fadiloglu, M. and Gure, A. (2001). Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production. Neurosci. Lett. 298, 139-141.
34. Giaccia, A., Siim, B. G. and Johnson, R. S. (2003). HIF-1 as a target for drug development. Nat. Rev. Drug Discov. 2, 803-811.
35. Gloor, S. M., Wachtel, M., Bolliger, M. F., Ishihara, H., Landmann, R. and Frei, K. (2001). Molecular and cellular permeability control at the blood-brain barrier. Brain Res. Rev. 36, 258-264.
36. Grimm, C., Wenzel, A., Groszer, M., Mayser, H., Seeliger, M., Samardzija, M., Bauer, C., Gassmann, M. and Reme, C. E. (2002). HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 8, 718-724.
37. Heeschen, C., Aicher, A., Lehmann, R., Fichtischerer, S., Vasa, M., Urbich, C., Mildner-Rihm, C., Martin, H., Zeiher, A. M. and Dimmeler, S. (2003). Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102, 1340-1346.
38. Hewitson, K. S., McNeill, L. A., Riordan, M. V., Tian, Y. M., Bullock, A. N., Welford, R. W., Elkins, J. M., Oldham, N. J., Bhattacharya, S., Gleadle, J. M. et al. (2002). Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277, 26351-26355.
39. Ihle, J. N. (1995). Cytokine receptor signalling. Nature 377, 591-594.
40. 2 sensing. Science 292, 464-468.
41. 2-regulated prolyl hydroxylation. Science 292, 468-472.
42. 2 tension. Am. J. Physiol. 271, C1172-C1180.
43. Junk, A. K., Mammis, A., Savitz, S. I., Singh, M., Roth, S., Malhotra, S., Rosenbaum, P. S., Cerami, A., Brines, M. and Rosenbaum, D. M. (2002). Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 99, 10659-10664.
44. Juul, S. (2002). Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage. Acta Paediatr. Suppl. 91, 36-42.
45. Juul, S. E., Harcum, J., Li, Y. and Christensen, R. D. (1997). Erythropoietin is present in the cerebrospinal fluid of neonates. J. Pediatr. 130, 428-430.
46. Juul, S. E., McPherson, R. J., Farrell, F. X., Jolliffe, L., Ness, D. J. and Gleason, C. A. (2004). Erythropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin. Biol. Neonate 85, 138-144.
47. Kawakami, M., Sekiguchi, M., Sato, K., Kozaki, S. and Takahashi, M. (2001). Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J. Biol. Chem. 276, 39469-39475.
48. Konishi, Y., Chui, D.-H., Hirose, H., Kunishita, T. and Tabira, T. (1993). Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res. 609, 29-35.
49. Koshimura, K., Murakami, Y., Sohmiya, M., Tanaka, J. and Kato, Y. (1999). Effects of erythropoietin on neuronal activity. J. Neurochem. 72, 2565-2572.
50. Koury, M. J. and Bondurant, M. C. (1990). Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248, 378-381.
51. Kremer, C., Breier, G., Risau, W. and Plate, K. H. (1997). Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. Cancer Res. 57, 3852-3859.
52. Lando, D., Peet, D. J., German, J. J., Whelan, D. A., Whitelaw, M. L. and Bruick, R. K. (2002a). FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466-1471.
53. Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J. and Whitelaw, M. L. (2002b). Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science 295, 858-861.
54. Lando, D., Gorman, J. J., Whitelaw, M. L. and Peet, D. J. (2003). Oxygen-dependent regulation of hypoxia-inducible factors by prolyl and asparaginyl hydroxylation. Eur. J. Biochem. 270, 781-790.
55. Lee, J. M., Grabb, M. C., Zipfel, G. J. and Choi, D. W. (2000). Brain tissue responses to ischemia. J. Clin. Invest. 106, 723-731.
56. Lewczuk, P., Hasselblatt, M., Kamrowski-Kruck, H., Heyer, A., Unzicker, C., Siren, A. L. and Ehrenreich, H. (2000). Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin. Neuroreport 11, 3485-3488.
57. Lipton, P. (1999). Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431-1568.
58. Liu, C., Shen, K., Liu, Z. Y. and Noguchi, C. T. (1997). Regulated human erythropoietin receptor expression in mouse brain. J. Biol Chem. 272, 32395-32400.
59. Marti, H. H. and Risau, W. (1998). Systemic hypoxia changes the organspecific distribution of vascular endothelial growth factor and its receptors. Proc. Natl. Acad. Sci. USA 95, 15809-15814.
60. Marti, H. H. and Risau, W. (1999). Angiogenesis in ischemic disease. Thromb. Haemost. 82 (Suppl.), 44-52.
61. Marti, H. H., Wenger, R. H., Rivas, L. A., Straumann, U., Digicaylioglu, M., Henn, V., Yonekawa, Y., Bauer, C. and Gassmann, M. (1996). Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 8, 666-676.
62. Marti, H. H., Gassmann, M., Wenger, R. H., Kvietikova, I., Morganti-Kossmann, M. C., Kossmann, T., Trentz, O. and Bauer, C. (1997). Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney Int. 51, 416-418.
63. Marti, H. H., Bernaudin, M., Petit, E. and Bauer, C. (2000). Neuroprotection and angiogenesis: a dual role of erythropoietin in brain ischemia. News Physiol. Sci. 15, 225-229.
64. 2 levels. J. Cell Sci. 116, 3041-3049.
65. Masuda, S., Masaya, N., Takahata, K., Konishi, Y., Gallyas, F., Tabira, T. and Sasaki, R. (1993). Functional erythropoietin-receptor of the cells with neural characteristics. J. Biol. Chem. 268, 11208-11216.
66. Masuda, S., Okano, M., Yamagishi, K., Nagao, M., Ueda, M. and Sasaki, R. (1994). A novel site of erythropoietin production: oxygen-dependent production in cultured rat astrocytes. J. Biol. Chem. 269, 19488-19493.
67. Masuda, S., Chikuma, M. and Sasaki, R. (1997). Insulin-like growth factors and insulin stimulate erythropoietin production in primary cultured astrocytes. Brain Res. 746, 63-70.
68. Morishita, E., Masuda, S., Nagao, M., Yasuda, Y. and Sasaki, R. (1997). Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76, 105-116.
69. Nagai, A., Nakagawa, E., Choi, H. B., Hatori, K., Kobayashi, S. and Kim, S. U. (2001). Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J. Neuropathol. Exp. Neurol. 60, 386-392.
70. Nicotera, P. and Lipton, S. A. (1999). Excitotoxins in neuronal apoptosis and necrosis. J. Cereb. Blood Flow Metab. 19, 583-591.
71. Nitta, K., Uchida, K., Kimata, N., Honda, K., Kobayashi, H., Kawashima, A., Yumura, W. and Nihei, H. (1999). Recombinant human erythropoietin stimulates vascular endothelial growth factor release by glomerular endothelial cells. Eur. J. Pharmacol. 373, 121-124.
72. Prass, K., Ruscher, K., Karsch, M., Isaev, N., Megow, D., Priller, J., Scharff, A., Dirnagl, U. and Meisel, A. (2002). Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J. Cereb. Blood Flow Metab. 22, 520-525.
73. Prass, K., Scharff, A., Ruscher, K., Löwl, D., Muselmann, C., Victorov, I., Kapinya, K., Dirnagl, U. and Meisel, A. (2003). Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 34, 1981-1986.
74. Pugh, C. W. and Ratcliffe, P. J. (2003). Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9, 677-684.
75. Ribatti, D., Presta, M., Vacca, A., Ria, R., Giuliani, R., Dell'Era, P., Nico, B., Roncali, L. and Dammacco, F. (1999). Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93, 2627-2636.
76. Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671-674.
77. Rosenberg, G. A. (1999). Ischemic brain edema. Prog. Cardiovasc. Dis. 42, 209-216.
78. Ruscher, K., Freyer, D., Karsch, M., Isaev, N., Megow, D., Sawitzki, B., Priller, J., Dirnagl, U. and Meisel, A. (2002). Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 22, 10291-10301.
79. Sadamoto, Y., Igase, K., Sakanaka, M., Sato, K., Otsuka, H., Sakaki, S., Masuda, S. and Sasaki, R. (1998). Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem. Biophys. Res. Commun. 253, 26-32.
80. Sakanaka, M., Wen, T. C., Matsuda, S., Masuda, S., Morishita, E., Nagao, M. and Sasaki, R. (1998). In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. USA 95, 4635-4640.
81. Semenza, G. L. (2000). HBF-1 and human disease: one highly involved factor. Genes Dev. 14, 1983-1991.
82. Semenza, G. L. and Wang, G. L. ( 1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12, 5447-5454.
83. Shingo, T., Sorokan, S. T., Shimazaki, T. and Weiss, S. (2001). Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J. Neurosci. 21, 9733-9743.
84. L and bcl-2. Blood 88, 1576-1582.
85. Sinor, A. D. and Greenberg, D. A. (2000). Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity. Neurosci. Lett. 290, 213-215.
86. Siren, A. L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A. et al. (2001a). Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. USA 98, 4044-4049.
87. Siren, A. L., Knerlich, F., Poser, W., Gleiter, C. H., Brück, W. and Ehrenreich, H. (2001b). Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol. 101, 271-276.
88. Stroka, D. M., Burkhardt, T., Desbaillets, I., Wenger, R. H., Bauer, C., Gassmann, M. and Candinas, D. (2001). HIF-1 is expressed in normoxic tissue and displays an organ specific regulation under systemic hypoxia. FASEB J. 15, 2445-2453.
89. Studer, L., Csete, M., Lee, S. H., Kabbani, N., Walikonis, J., Wold, B. and McKay, R. (2000). Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J. Neurosci. 20, 7377-7383.
90. Sugawa, M., Sakurai, Y., Ishikawa-Ieda, Y., Suzuki, H. and Asou, H. (2002). Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci. Res. 44, 391-403.
91. Tan, C. C., Eckardt, K.-U., Firth, J. D. and Ratcliffe, P. J. (1992). Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am. J. Physiol. 263, F474-F481.
92. Victoria, M., Arroyo, A., Castilla, M. A., Pacheco, F. R. G., Tan, D., Riesco, A., Casado, S. and Caramelo, C. (1998). Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation. J. Am. Soc. Nephrol 9, 1998-2004.
93. Weber, A., Maier, R. F., Hoffmann, U., Grips, M., Hoppenz, M., Aktas, A. G., Heinemann, U., Obladen, M. and Schuchmann, S. (2002). Erythropoietin improves synaptic transmission during and following ischemia in rat hippocampal slice cultures. Brain Res. 958, 305-311.
94. L expression. J. Neurosci. Res. 67, 795-803.
95. Wenger, R. H. (2000). Mammalian oxygen sensing, signalling and gene regulation. J. Exp. Biol. 203, 1253-1263.
96. 2-regulated gene expression. FASEB J. 16, 1151-1162.
97. Wiessner, C., Allegrini, P. R., Ekatodramis, D., Jewell, U. R., Stallmach, T. and Gassmann, M. (2001). Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J. Cereb. Blood Flow Metab. 21, 857-864.
98. Yamaji, R., Okada, T., Moriya, M., Naito, M., Tsuruo, T., Miyatake, K. and Nakano, Y. (1996). Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur. J. Biochem. 239, 494-500.
99. Yamamoto, M., Koshimura, K., Kawaguchi, M., Sohmiya, M., Murakami, Y. and Kato, Y. (2002). Stimulating effect of erythropoietin on the release of dopamine and acetylcholine from the rat brain slice. Neurosci. Lett. 292, 131-133.
100. Yasuda, Y., Masuda, S., Chikuma, M., Inoue, K., Nagao, M. and Sasaki, R. (1998). Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. J. Biol. Chem. 273, 25381-25387.
101. Yu, X., Lin, C.-S., Costantini, F. and Noguchi, C. T. (2001). The human erythropoietin receptor gene rescues erythropoiesis and developmental defects in the erythropoietin null mouse. Blood 98, 475-477.